Page last updated: 2024-10-27

gaboxadol and Disorders of Excessive Somnolence

gaboxadol has been researched along with Disorders of Excessive Somnolence in 2 studies

gaboxadol: GABA agonist; inhibitor of GABA uptake systems; structure

Disorders of Excessive Somnolence: Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)

Research Excerpts

ExcerptRelevanceReference
"Gaboxadol was generally well-tolerated; there were no serious adverse experiences and no subjects discontinued due to an adverse experience."2.74Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects. ( Boyle, J; Cerchio, K; Cummings, C; Gargano, C; Lines, C; McCrea, J; Wolford, D, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Walsh, JK1
Snyder, E1
Hall, J1
Randazzo, AC1
Griffin, K1
Groeger, J1
Eisenstein, R1
Feren, SD1
Dickey, P1
Schweitzer, PK1
Boyle, J1
Wolford, D1
Gargano, C1
McCrea, J1
Cummings, C1
Cerchio, K1
Lines, C1

Trials

2 trials available for gaboxadol and Disorders of Excessive Somnolence

ArticleYear
Slow wave sleep enhancement with gaboxadol reduces daytime sleepiness during sleep restriction.
    Sleep, 2008, Volume: 31, Issue:5

    Topics: Adult; Affect; Arousal; Attention; Circadian Rhythm; Disorders of Excessive Somnolence; Double-Blind

2008
Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects.
    Human psychopharmacology, 2009, Volume: 24, Issue:1

    Topics: Administration, Oral; Aged; Cross-Over Studies; Disorders of Excessive Somnolence; Double-Blind Meth

2009